Robert D Christensen
Physician in Layton, UT
License number
Utah 159737-8905
Issued Date
Jun 7, 1983
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician/Surgeon CS (Schedule 2-5)
Address
Address
Layton, UT
Education
COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS AND SURG
Professional information
Methods And Compositions For Irrigation Of Mucosal Tissues
US Patent:
2013007, Mar 28, 2013
Filed:
Mar 26, 2012
Appl. No.:
13/430594
Inventors:
Robert D. Christensen - Layton UT, US
Edward B. Walker - Ogden UT, US
Edward B. Walker - Ogden UT, US
International Classification:
A61K 33/42
US Classification:
424602
Abstract:
A synthetic endotracheal irrigant for preventing, treating, and reducing infections, including mucosal infections in patients, including infants. A method for producing a formulation of the synthetic endotracheal irrigant with a water content of about 98% (w/w) to about 99.9(w/w) and a total mineral content of less than about 5.0% (w/w), including a sodium content of less than about 2.0% (w/w). The synthetic endotracheal irrigant excludes protein.
Infant Formula Compositions For Neonates Lacking Mother's Own Colostrum And Method Of Making
US Patent:
2010018, Jul 22, 2010
Filed:
Jan 21, 2010
Appl. No.:
12/691630
Inventors:
Robert D. Christensen - Layton UT, US
International Classification:
A23L 1/305, A23L 1/302, A23L 1/304, A23C 9/152, A23C 9/158
US Classification:
426 72, 426656, 426580, 426602, 426 74, 426590, 426311
Abstract:
Colostrum solutions, their formulations and a method of making the solutions are presented. These solutions could be used in situations where the mother is not able to naturally provide colostrum to an infant.
Ampoule With Protective Sleeve For Contamination Prevention
US Patent:
2012026, Oct 25, 2012
Filed:
Oct 19, 2011
Appl. No.:
13/277122
Inventors:
Chris Cindrich - Draper UT, US
Robert D. Christensen - Layton UT, US
Robert D. Christensen - Layton UT, US
International Classification:
B65D 49/00
US Classification:
215 49
Abstract:
An apparatus includes and ampoule and a protective sleeve. The ampoule includes a body portion and an openable end portion. The body portion defines an internal cavity for containment of a substance. The openable end portion is configured to be opened by removal of a distal section, which upon removal creates an opening into the internal cavity of the body portion for liberation of the substance from the internal cavity. The protective sleeve is disposed over at least a portion of the openable end portion. The protective sleeve provides a contamination barrier to prevent contamination of an outer surface of the openable end portion covered by the protective sleeve.